» Articles » PMID: 1647439

Okadaic Acid Inhibition of KCl Cotransport. Evidence That Protein Dephosphorylation is Necessary for Activation of Transport by Either Cell Swelling or N-ethylmaleimide

Overview
Journal J Gen Physiol
Specialty Physiology
Date 1991 Apr 1
PMID 1647439
Citations 60
Authors
Affiliations
Soon will be listed here.
Abstract

The mechanism of activation of KCl cotransport has been examined in rabbit red blood cells. Previous work has provided evidence that a net dephosphorylation is required for activation of transport by cell swelling. In the present study okadaic acid, an inhibitor of protein phosphatases, was used to test this idea in more detail. We find that okadaic acid strongly inhibits swelling-stimulated KCl cotransport. The IC50 for okadaic acid is approximately 40 nM, consistent with the involvement of type 1 protein phosphatase in transport activation. N-Ethylmaleimide (NEM) is well known to activate KCl cotransport in cells of normal volume. Okadaic acid, added before NEM, inhibits the activation of transport by NEM, indicating that a dephosphorylation is necessary for the NEM effect. Okadaic acid added after NEM inhibits transport only very slightly. After a brief exposure to NEM and rapid removal of unreacted NEM, KCl cotransport activates with a time delay that is similar to that for swelling activation. Okadaic acid causes a slight increase in the delay time. These findings are all consistent with the idea that NEM activates transport not by a direct action on the transport protein but by altering a phosphorylation-dephosphorylation cycle. The simplest hypothesis that is consistent with the data is that both cell swelling and NEM cause inhibition of a protein kinase. Kinase inhibition causes net dephosphorylation of some key substrate (not necessarily the transport protein); dephosphorylation of this substrate, probably by type 1 protein phosphatase, causes transport activation.

Citing Articles

The Chemistry of Phytoplankton.

Liu X, Bian Z, Hu S, Dickinson C, Benjamin M, Jia J Chem Rev. 2024; 124(23):13099-13177.

PMID: 39571071 PMC: 11638913. DOI: 10.1021/acs.chemrev.4c00177.


Combination administration of alprazolam and N-Ethylmaleimide synergistically enhances sleep behaviors in mice with no potential CNS side effects.

Zhu S, Shi J, Zhang Y, Chen X, Shi T, Li L PeerJ. 2024; 12:e17342.

PMID: 38737745 PMC: 11086308. DOI: 10.7717/peerj.17342.


Pharmacology of Compounds Targeting Cation-Chloride Cotransporter Physiology.

Delpire E, Terker A, Gagnon K Handb Exp Pharmacol. 2023; 283:249-284.

PMID: 37563251 PMC: 10823342. DOI: 10.1007/164_2023_692.


The K-Cl cotransporter-3 in the mammalian kidney.

Ferdaus M, Delpire E Curr Opin Nephrol Hypertens. 2023; 32(5):482-489.

PMID: 37530088 PMC: 10403293. DOI: 10.1097/MNH.0000000000000911.


Does Plasma Inhibit the Activity of KCl Cotransport in Red Cells From LK Sheep?.

Lu D, Hannemann A, Gibson J Front Physiol. 2022; 13:904280.

PMID: 35685289 PMC: 9171837. DOI: 10.3389/fphys.2022.904280.


References
1.
Lefevre P, Marshall J . The atachment of phloretin and analogues to human erythrocytes in connection with inhibition of sugar transport. J Biol Chem. 1959; 234:3022-6. View

2.
Kregenow F . The response of duck erythrocytes to nonhemolytic hypotonic media. Evidence for a volume-controlling mechanism. J Gen Physiol. 1971; 58(4):372-95. PMC: 2226034. DOI: 10.1085/jgp.58.4.372. View

3.
Inoue Y, Saijoh K, Sumino K . Action of mercurials on activity of partially purified soluble protein kinase C from mice brain. Pharmacol Toxicol. 1988; 62(5):278-81. DOI: 10.1111/j.1600-0773.1988.tb01887.x. View

4.
Brugnara C, Van Ha T, Tosteson D . Properties of K+ transport in resealed human erythrocyte ghosts. Am J Physiol. 1988; 255(3 Pt 1):C346-56. DOI: 10.1152/ajpcell.1988.255.3.C346. View

5.
Brugnara C, Van Ha T, Tosteson D . Role of chloride in potassium transport through a K-Cl cotransport system in human red blood cells. Am J Physiol. 1989; 256(5 Pt 1):C994-1003. DOI: 10.1152/ajpcell.1989.256.5.C994. View